Zhengguang Zhang

Dr. Zhengguang Zhang


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 July 2021 in Inflammopharmacology
Verified
Journal Article
Closed access
PDF file
ZZZhengguang Zhang
Zhengguang Zhang
YGYuanyuan Guo
Yuanyuan Guo
MCMeijuan Chen
Meijuan Chen
FCFeiyan Chen
Feiyan Chen
BLBing Liu
Bing Liu
CSCunsi Shen
Cunsi Shen

1 March 2024 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
ZLZixian Liu
Zixian Liu
TLTianming Lu
Tianming Lu
RQRuoning Qian
Ruoning Qian
ZWZian Wang
Zian Wang
Ruogu QiRuogu Qi
Ruogu Qi
ZZZhengguang Zhang
Zhengguang Zhang
Background: Cancer continues to be a prominent issue in the field of medicine, as demonstrated by recent studies emphasizing the significant role of autophagy in the development of cancer. Traditional Chinese Medicine (TCM) provides a variety of anti-tumor agents capable of regulating autophagy. However, the clinical application of autophagy-modulating compounds derived from TCM is impeded by their restricted water solubility and bioavailability. To overcome this challenge, the utilization of nanotechnology has been suggested as a potential solution. Nonetheless, the current body of literature on nanoparticles delivering TCM-derived autophagy-modulating anti-tumor compounds for cancer treatment is limited, lacking comprehensive summaries and detailed descriptions. Methods: Up to November 2023, a comprehensive research study was conducted to gather relevant data using a variety of databases, including PubMed, ScienceDirect, Springer Link, Web of Science, and CNKI. The keywords utilized in this investigation included “autophagy”, “nanoparticles”, “traditional Chinese medicine” and “anticancer”. Results: This review provides a comprehensive analysis of the potential of nanotechnology in overcoming delivery challenges and enhancing the anti-cancer properties of autophagy-modulating compounds in TCM. The evaluation is based on a synthesis of different classes of autophagy-modulating compounds in TCM, their mechanisms of action in cancer treatment, and their potential benefits as reported in various scholarly sources. The findings indicate that nanotechnology shows potential in enhancing the availability of autophagy-modulating agents in TCM, thereby opening up a plethora of potential therapeutic avenues. Conclusion: Nanotechnology has the potential to enhance the anti-tumor efficacy of autophagy-modulating compounds in traditional TCM, through regulation of autophagy.

1 September 2024 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
ZZZhengguang Zhang
Zhengguang Zhang
MLMin Li
Min Li
XZXiaolong Zhang
Xiaolong Zhang
FZFuqiong Zhou
Fuqiong Zhou
Reactive oxygen species (ROS) encompass a diverse group of chemically reactive molecules or ions distinguished by their substantial oxidative potential. Empirical studies have shown that the targeted administration of high toxic concentrations of ROS can effectively induce tumor cell death in various types. Numerous bioactive ingredients derived from traditional Chinese medicine (TCM), recognized for their ROS-inducing properties, have demonstrated significant anti-tumor activity. Nonetheless, their clinical application has been hindered by challenges such as low solubility, limited bioavailability, and poor selectivity. Multifunctional nanoformulations possess the potential to overcome these challenges and enhance the anticancer efficacy of ROS-inducing active compounds. Through extensive searches of various academic databases and a thorough review and screening of relevant literature, this study aims to systematically summarize and generalize multiple active ingredients in TCM that induce ROS generation, along with their multifunctional nanoformulations, from various perspectives. The objective is to provide new insights and references for fundamental cancer research and clinical treatments. Furthermore, we acknowledge that although numerous active ingredients and their nanoformulations in TCM have demonstrated ROS-inducing and anti-tumor potentials, potentially offering novel strategies for tumor therapy, the underlying mechanisms require further comprehensive investigation.


26 February 2009 in Medizinische Klinik
Verified
Journal Article
Closed access
PDF file
ZZZhengguang Zhang
Zhengguang Zhang
JSJochen Schmitt
Jochen Schmitt
GWGottfried Wozel
Gottfried Wozel
WKWilhelm Kirch
Wilhelm Kirch

13 February 2023 in Drug Development Research
Verified
Journal Article
Closed access
ZZZhengguang Zhang
Zhengguang Zhang
CSCunsi Shen
Cunsi Shen
FZFuqiong Zhou
Fuqiong Zhou
YZYajie Zhang
Yajie Zhang